1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for France
Preclinical Imaging Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in France
Preclinical Imaging Market
4.
France Preclinical Imaging Market
by Product
4.1.
Modalities
4.1.1. Magnetic Resonance Imaging
4.1.2. Single-photon Emission Computed Tomography
4.1.3. Micro-computed Tomography
4.1.4. Positron Emission Tomography
4.1.5. Magnetic Particle Imaging
4.1.6. Optical Imaging
4.2.
Reagents
4.2.1. Bioluminescent Imaging Reagents
4.2.2. Fluorescent Imaging Reagents
4.2.3. PET Radioactive Tracers
4.2.4. X-ray CT Contrasting Reagents
4.2.5. MRI Contrasting Reagents
4.2.6. Ultrasound Contrasting Reagents
5.
France Preclinical Imaging Market
by Application
5.1.
Research and Development
5.2.
Drug Discovery
6.
France Preclinical Imaging Market
by End-user
6.1.
Pharmaceutical Companies
6.2.
Biotech Companies
6.3.
Research Institutes
7.
Company Profiles
7.1.
Company 1
7.2.
Company 2
7.3.
Company 3
7.4.
Company 4
7.5.
Company 5
1.
Report Overview
1.1.
Report Description
1.2.
Research Methods
1.3.
Research Approaches
2.
Executive Summary
3.
Market Overview
3.1.
Introduction
3.2.
Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3.
PEST-Analysis
3.4.
Porter's Diamond Model for France
Preclinical Imaging Market
3.5.
IGR-Growth Matrix Analysis
3.6.
Competitive Landscape in France
Preclinical Imaging Market
4.
France Preclinical Imaging Market
by Product
4.1.
Modalities
4.1.1. Magnetic Resonance Imaging
4.1.2. Single-photon Emission Computed Tomography
4.1.3. Micro-computed Tomography
4.1.4. Positron Emission Tomography
4.1.5. Magnetic Particle Imaging
4.1.6. Optical Imaging
4.2.
Reagents
4.2.1. Bioluminescent Imaging Reagents
4.2.2. Fluorescent Imaging Reagents
4.2.3. PET Radioactive Tracers
4.2.4. X-ray CT Contrasting Reagents
4.2.5. MRI Contrasting Reagents
4.2.6. Ultrasound Contrasting Reagents
5.
France Preclinical Imaging Market
by Application
5.1.
Research and Development
5.2.
Drug Discovery
6.
France Preclinical Imaging Market
by End-user
6.1.
Pharmaceutical Companies
6.2.
Biotech Companies
6.3.
Research Institutes
7.
Company Profiles
7.1.
Company 1
7.2.
Company 2
7.3.
Company 3
7.4.
Company 4
7.5.
Company 5